Cummings James F. (CIK 1886760) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-31). Recent activity: Sell VXRT (3,292 shares), Sell VXRT (30,551 shares), Sell VXRT (6,772 shares), Buy VXRT (227,000 shares), Sell VXRT (7,965 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-31 | Vaxart, Inc. (VXRT) | Chief Medical Officer | Sell | 3,292 | $2,140 |
| 2026-03-26 | Vaxart, Inc. (VXRT) | Chief Medical Officer | Sell | 30,551 | $21,080 |
| 2026-03-20 | Vaxart, Inc. (VXRT) | Chief Medical Officer | Sell | 6,772 | $4,266 |
| 2026-03-18 | Vaxart, Inc. (VXRT) | Chief Medical Officer | Buy | 227,000 | $0 |
| 2026-02-05 | Vaxart, Inc. (VXRT) | Chief Medical Officer | Sell | 7,965 | $4,859 |
| 2025-04-01 | Vaxart, Inc. (VXRT) | Chief Medical Officer | Sell | 3,292 | $1,383 |
| 2025-03-26 | Vaxart, Inc. (VXRT) | Chief Medical Officer | Buy | 406,000 | $0 |
| 2025-03-20 | Vaxart, Inc. (VXRT) | Chief Medical Officer | Sell | 3,267 | $2,450 |
| 2025-03-20 | Vaxart, Inc. (VXRT) | Chief Medical Officer | Sell | 6,772 | $3,860 |
| 2025-02-04 | Vaxart, Inc. (VXRT) | Chief Medical Officer | Sell | 7,964 | $5,416 |
Source: SEC Form 4 filings · as of 2026-03-31